Research Papers

25 of 148 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Tissue levels of suppressor of cytokine signaling-3 (SOCS-3) in mycosis fungoides.
Nada HR; Rashed LA; Salman OO; Abdallah NMA; Abdelhady MM.
Arch Dermatol Res (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Financial stress among skin cancer patients: a cross-sectional review of the 2013-2018 National Health Interview Survey.
Cwalina TB; Jella TK; Tripathi R; Carroll BT.
Arch Dermatol Res (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Needs and preferences of patients regarding atopic dermatitis care in the era of new therapeutic options: a qualitative…
de Wijs LEM; van Egmond S; Devillers ACA; Nijsten T; Hijnen D; Lugtenberg M.
Arch Dermatol Res (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
NF-кB c-Rel modulates pre-fibrotic changes in human fibroblasts.
Micus LC; Trautschold-Krause FS; Jelit AL; Schön MP; Lorenz VN.
Arch Dermatol Res (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
Levamisole-induced and COVID-19-induced retiform purpura: two overlapping, emerging clinical syndromes.
Keim CK; Schwartz RA; Kapila R.
Arch Dermatol Res (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
Associations between onychomycosis and COVID-19 clinical outcomes: a retrospective cohort study from a US metropolitan …
Rakita U; Kaundinya T; Guraya A; Nelson K; Maner B; Manjunath J; Schwartzman G; Lane B; Silverberg JI.
Arch Dermatol Res (Unknown)
Published: 2021
3/6 Transparent
Funding Declared
Impact of COVID-19 on dermatologic surgery: experience of a Midwestern academic practice.
Hamel R; Pollard B; Council ML.
Arch Dermatol Res (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
Atopic dermatitis is not associated with SARS-CoV-2 outcomes.
Rakita U; Kaundinya T; Guraya A; Nelson K; Maner B; Manjunath J; Schwartzman G; Lane B; Silverberg JI.
Arch Dermatol Res (Unknown)
Published: 2021
3/6 Transparent
Funding Declared
Local, non-systemic, and minimally invasive therapies for calcinosis cutis: a systematic review.
Nowaczyk J; Zawistowski M; Fiedor P.
Arch Dermatol Res (Unknown)
Published: 2021
3/6 Transparent
Registered Funding Declared
Comorbidities and treatment patterns in adult patients with atopic dermatitis: results from a nationwide multicenter st…
Campanati A; Bianchelli T; Gesuita R; Foti C; Malara G; Micali G; Amerio P; Rongioletti F; Corazza M; Patrizi A; Peris K; Pimpinelli N; Parodi A; Fargnoli MC; Cannavo SP; Pigatto P; Pellacani G; Ferrucci SM; Argenziano G; Cusano F; Fabbrocini G; Stingeni L; Potenza MC; Romanelli M; Bianchi L; Offidani A; and collaborators.
Arch Dermatol Res (Unknown)
Published: 2021
3/6 Transparent
Funding Declared
Home-based devices in dermatology: a systematic review of safety and efficacy.
Cohen M; Austin E; Masub N; Kurtti A; George C; Jagdeo J.
Arch Dermatol Res (Unknown)
Published: 2021
1/6 Transparent
Profiling of microRNAs in actinic keratosis and cutaneous squamous cell carcinoma patients.
Dańczak-Pazdrowska A; Pazdrowski J; Polańska A; Basta B; Schneider A; Kowalczyk MJ; Golusiński P; Golusiński W; Adamski Z; Żaba R; Masternak MM.
Arch Dermatol Res (Unknown)
Published: 2021
Dermoscopy of early melanomas: variation according to the anatomic site.
Tognetti L; Cartocci A; Cinotti E; Moscarella E; Farnetani F; Carrera C; Lallas A; Tiodorovic D; Longo C; Puig S; Perrot JL; Argenziano G; Pellacani G; Cataldo G; Balistreri A; Cevenini G; Rubegni P.
Arch Dermatol Res (Unknown)
Published: 2021
3/6 Transparent
Funding Declared
Melanoma is associated with an increased risk of bullous pemphigoid: a large population-based longitudinal study.
Kridin K; Hundt JE; Ludwig RJ; Amber KT; Bitan DT; Cohen AD.
Arch Dermatol Res (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
Complex skin cancer treatment requiring reconstructive plastic surgery: an interview study on the experiences and needs…
van Egmond S; Wakkee M; Hoogenraad M; Korfage IJ; Mureau MAM; Lugtenberg M.
Arch Dermatol Res (Unknown)
Published: 2021
2/6 Transparent
Dermatopathology practice in the era of COVID-19.
Abdelkader HA.
Arch Dermatol Res (Unknown)
Published: 2021
3/6 Transparent
Funding Declared
A fast and effective solution for ingrown toenail: Creation of a 2-mm space between tissue and nail by sutureless later…
Unal E; Yuksekdag S.
Arch Dermatol Res (Unknown)
Published: 2021
3/6 Transparent
Funding Declared
A call to action: why medical education curriculum needs to encourage young physicians to innovate.
Sharma AA; Lee KC; Garibyan L.
Arch Dermatol Res (Unknown)
Published: 2021
2/6 Transparent
Evaluation of patient attitudes towards the technical experience of synchronous teledermatology in the era of COVID-19.
Pearlman RL; Le PB; Brodell RT; Nahar VK.
Arch Dermatol Res (Unknown)
Published: 2021
4/6 Transparent
Data Funding Declared
Dermatological aspects of SARS-CoV-2 infection: mechanisms and manifestations.
Garduño-Soto M; Choreño-Parra JA; Cazarin-Barrientos J.
Arch Dermatol Res (Unknown)
Published: 2020
2/6 Transparent
Funding Declared
Teledermatology: current indications and considerations for future use.
Beer J; Hadeler E; Calume A; Gitlow H; Nouri K.
Arch Dermatol Res (Unknown)
Published: 2020
2/6 Transparent
Funding Declared
Destructive and topical treatments of skin lesions in organ transplant recipients and relation to skin cancer.
Green AC; Way M; Oster M; Plasmeijer EI; Jiyad Z; O'Rourke P; Miura K; Campbell S; Isbel N; Chambers DC; Hopkins P; Ferguson LE; Davis MB; Whiteman DC; Soyer HP; Marquart L.
Arch Dermatol Res (Unknown)
Published: 2020
2/6 Transparent
Funding Declared
Depressive symptoms and insecure attachment predict disability and quality of life in psoriasis independently from dise…
Esposito M; Giunta A; Nanni RC; Criscuolo S; Manfreda V; Del Duca E; Bianchi L; Troisi A.
Arch Dermatol Res (Unknown)
Published: 2020
2/6 Transparent
Funding Declared
Thyroxine restores severely impaired cutaneous re-epithelialisation and angiogenesis in a novel preclinical assay for s…
Post H; Hundt JE; Zhang G; Depping R; Rose C; Langan EA; Paus R.
Arch Dermatol Res (Unknown)
Published: 2020
2/6 Transparent
Funding Declared
Distance learning in the era of COVID-19.
Schneider SL; Council ML.
Arch Dermatol Res (Unknown)
Published: 2020
1/6 Transparent